Xiao Xueqi, Liao Zhiyong, Zou Jian
Zhejiang Provincial Key Laboratory for Water Environment and Marine Biological Resources Protection, College of Life and Environmental Science, Wenzhou University, Wenzhou, China.
Department of Ophthalmology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
Adv Ophthalmol Pract Res. 2023 Jun 10;3(3):126-133. doi: 10.1016/j.aopr.2023.05.004. eCollection 2023 Aug-Sep.
Retinal diseases characterized with irreversible loss of retinal nerve cells, such as optic atrophy and retinal degeneration, are the main causes of blindness. Current treatments for these diseases are very limited. An emerging treatment strategy is to induce the reprogramming of Müller glial cells to generate new retinal nerve cells, which could potentially restore vision.
Müller glial cells are the predominant glial cells in retinae and play multiple roles to maintain retinal homeostasis. In lower vertebrates, such as in zebrafish, Müller glial cells can undergo cell reprogramming to regenerate new retinal neurons in response to various damage factors, while in mammals, this ability is limited. Interestingly, with proper treatments, Müller glial cells can display the potential for regeneration of retinal neurons in mammalian retinae. Recent studies have revealed that dozens of genetic and epigenetic regulators play a vital role in inducing the reprogramming of Müller glial cells in vivo. This review summarizes these critical regulators for Müller glial cell reprogramming and highlights their differences between zebrafish and mammals.
A number of factors have been identified as the important regulators in Müller glial cell reprogramming. The early response of Müller glial cells upon acute retinal injury, such as the regulation in the exit from quiescent state, the initiation of reactive gliosis, and the re-entry of cell cycle of Müller glial cells, displays significant difference between mouse and zebrafish, which may be mediated by the diverse regulation of Notch and TGFβ (transforming growth factor-β) isoforms and different chromatin accessibility.
以视网膜神经细胞不可逆丧失为特征的视网膜疾病,如视神经萎缩和视网膜变性,是失明的主要原因。目前针对这些疾病的治疗方法非常有限。一种新兴的治疗策略是诱导穆勒胶质细胞重编程以产生新的视网膜神经细胞,这有可能恢复视力。
穆勒胶质细胞是视网膜中主要的胶质细胞,在维持视网膜内环境稳定方面发挥多种作用。在低等脊椎动物中,如斑马鱼,穆勒胶质细胞可响应各种损伤因素进行细胞重编程以再生新的视网膜神经元,而在哺乳动物中,这种能力有限。有趣的是,经过适当治疗,穆勒胶质细胞在哺乳动物视网膜中可展现出再生视网膜神经元的潜力。最近的研究表明,数十种基因和表观遗传调节因子在体内诱导穆勒胶质细胞重编程中起关键作用。本综述总结了这些穆勒胶质细胞重编程的关键调节因子,并强调了它们在斑马鱼和哺乳动物之间的差异。
已确定多种因素是穆勒胶质细胞重编程的重要调节因子。穆勒胶质细胞在急性视网膜损伤后的早期反应,如从静止状态退出的调节、反应性胶质增生的启动以及穆勒胶质细胞细胞周期的重新进入,在小鼠和斑马鱼之间存在显著差异,这可能由Notch和TGFβ(转化生长因子-β)异构体的不同调节以及不同的染色质可及性介导。